Cancers· 2026Q1· Review

ELN vs. IPSS-M in MDS/AML: Which Prognostic System Should Guide Clinical Decision-Making?

Maria Liga, A. N. Georgopoulou, Dimitrios Tsokanas, Alexandros Spyridonidis et al.

0citations
Q1SCImago
2026year

Short summary

IPSS-M is the preferred framework for baseline prognostic assessment of MDS/AML, showing preserved prognostic discrimination, while direct application of ELN 2022 results in adverse-risk compression and limited discrimination.

AI-generated from the title and abstract; the full text is not read.

TakeawaysIn the app

Key pointsIn the app

Ask the paperIn the app

The rest is in the Pofolia app

Takeaways, key points and questions to the paper; new summaries every day for your field. Free.

Get it on Google Play Download on the App Store

Field: Hematology

HematologyMedicine